Skip to content
Pill with imprint TEVA 4067, white, capsule, 18 mm (Prazosin Hydrochloride 1 mg)

“Prazosin hydrochloride capsules USP are available as follows: 1 mg: An ivory opaque capsule, filled with white powder, imprinted with "TEVA" on the cap and "4067" on the body, containing prazosin hydrochloride, USP equivalent to 1 mg of prazosin”

TEVA 4067 pill

Pill with imprint TEVA 4067 is white, capsule, 18 mm and has been identified as Prazosin Hydrochloride 1 mg. It is used for high blood pressure, Raynaud's and an enlarged prostate (BPH). It is supplied by Aidarex Pharmaceuticals LLC.

Prazosin Hydrochloride 1 mg

Imprint
TEVA 4067
Strength
1 mg
Used for
High blood pressure, Raynaud's and an enlarged prostate (BPH)
Color
White
Shape
Capsule / oblong
Size
18 mm
Score
No score line
Form
Capsule
Manufacturer
Aidarex Pharmaceuticals LLC
Drug class
Alpha blocker (prostate and blood pressure medicine)
NDC
33261-860, 0093-4067, 33261-860-30, 33261-860-60, 64725-4067, 64725-4067-1, 61919-910, 61919-910-60, 61919-910-90, 50090-0379, 50090-0379-1, 63629-8750, 63629-8750-1, 63629-8756, 63629-8756-1, 55154-8181, 68084-996, 55154-8181-0, 0093-4067-01, 0093-4067-10, 68084-996-11, 68084-996-01, 68788-7335, 68788-7335-3, 68788-7335-6, 68788-7335-9, 68788-7335-1

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Prazosin pills and guides

What is Prazosin used for?

Prazosin is used for high blood pressure, Raynaud's and an enlarged prostate (BPH).

Medicine type
Alpha blocker (prostate and blood pressure medicine)
Official uses from the US prescribing label

Prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC). Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly. Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal. Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy. Prazosin hydrochloride capsules can be used alone or in combination with other antihypertensive drugs such as diuretics or beta-adrenergic blocking agents.

From the FDA-approved label on DailyMed (published Sep 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows TEVA 4067. The parts can be split between the two sides, so turn the pill over and check both.
  • It is white, capsule, 18 mm.
  • The score line, coating and any logo match the photo.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Prazosin Hydrochloride

Inactive: Anhydrous Lactose, Magnesium Stearate, Starch, Corn, D&c Yellow No. 10, Titanium Dioxide

Also distributed by

Tya Pharmaceuticals, Direct Rx, A-S Medication Solutions, Bryant Ranch Prepack, Cardinal Health 107, LLC, Teva Pharmaceuticals Usa, Inc., American Health Packaging, Preferred Pharmaceuticals Inc.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Prazosin pills